|
COQ3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.712400E-02 |
| Normal-vs-Stage2 |
1.035030E-01 |
| Normal-vs-Stage3 |
2.585800E-02 |
| Normal-vs-Stage4 |
5.602500E-04 |
| Stage1-vs-Stage2 |
4.744700E-03 |
| Stage1-vs-Stage3 |
4.678000E-01 |
| Stage1-vs-Stage4 |
7.083600E-03 |
| Stage2-vs-Stage3 |
2.384100E-03 |
| Stage2-vs-Stage4 |
1.375120E-04 |
| Stage3-vs-Stage4 |
7.546300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.003100E-03 |
| Normal-vs-AfricanAmerican |
2.392800E-01 |
| Normal-vs-Asian |
6.678200E-01 |
| Caucasian-vs-AfricanAmerican |
4.874600E-01 |
| Caucasian-vs-Asian |
2.032200E-02 |
| AfricanAmerican-vs-Asian |
3.675800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.619600E-02 |
| Normal-vs-Female |
1.390230E-01 |
| Male-vs-Female |
5.427800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.838400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.192300E-02 |
| Normal-vs-Age(61-80Yrs) |
9.685600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.159000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.332800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.371900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.412800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.391600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.961800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.791600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.613610E-02 |
| Classical-VS-Follicular |
4.82779999999572E-06 |
| Classical-VS-Other |
8.513600E-01 |
| Classical-VS-Normal |
8.417100E-03 |
| Tall-VS-Follicular |
7.32789999791095E-08 |
| Tall-VS-Other |
1.419050E-01 |
| Tall-VS-Normal |
2.231500E-04 |
| Follicular-VS-Other |
1.688060E-02 |
| Follicular-VS-Normal |
7.152400E-02 |
| Other-VS-Normal |
3.952400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.633800E-01 |
| Normal-vs-N1 |
1.575210E-04 |
| N0-vs-N1 |
5.9801000000026E-05 |
|
|
